Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | Medicilon assists Carephar first acid blocker approved for sales in ChinaBy: Medicilon Shanghai Medicilon Inc. (Medicilon), as a partner of Carephar, with its solid research and development capabilities, has provided Carenoprazan's research and development from compound design to preclinical candidate compounds, as well as most of the in vitro H+K+-ATPase testing and other services and the Carenoprazan has been successfully approved. Medicilon Drug Discovery Services Open the door to innovative medicine with science and expertise Drug discovery (https://www.medicilon.com/ Medicilon can undertake different kind of chemistry services such as custom synthesis, compound library construction, SAR compound synthesis and screening, and compound structure and biological activity optimization. In terms of biology services, Medicilon could provide reparation of hybridoma antibody/genetic engineering antibody, protein expression and purification, X-ray crystal structure analysis/cryo- End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|